Ji Young Yoo

Assistant Professor

The University of Texas Health Science Center at Houston School of Public Health

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Ji Young Yoo is an Assistant Professor at The University of Texas Health Science Center at Houston School of Public Health in the United States. Her research focuses on the tumor microenvironment, oncolytic virotherapy, and therapeutic strategies for various forms of cancer, including glioblastoma and triple-negative breast cancer. Recent publications explore the implications of immune cells in oncolytic therapies and novel approaches to enhance antitumor efficacy.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Balveen Kaur

Professor and Associate Director

Augusta University

UNITED STATES

View details

Yoshihiro Otani

Assistant Professor

Okayama University Hospital

JAPAN

View details

Hyun Kyoung Lee

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ji Young Yoo

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapy.

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation

Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus

The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer

Implications of immune cells in oncolytic herpes simplex virotherapy for glioma.

NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy

Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib

Inhibiting protein phosphatase 2A increases the antitumor effect of protein arginine methyltransferase 5 inhibition in models of glioblastoma.

Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy.

MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin.

Collaborators (3)

Balveen Kaur

Yoshihiro Otani

Hyun Kyoung Lee

Make your next move.